230 filings
Page 3 of 12
6-K
9toc697n ro
2 Jun 23
SciSparc Announces Successful Final Phase IIa Results, Meeting End Points of its Phase IIa Alzheimer Disease Patients with Agitation Trial
9:04am
6-K
wx09w8dfauyqwfau4 id
30 May 23
SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP
4:01pm
6-K
mvgh0o c0p
16 May 23
At-The-Market Issuance Sales Agreement
8:06pm
6-K
y3wogel 3z8
8 May 23
Report of Foreign Private Issuer
8:23am
6-K
arvydp60x1dcvucsoa
5 May 23
Report of Foreign Private Issuer
4:01pm
6-K
hmbn6a9by
2 May 23
SciSparc Completed Treatment of Last Patient Enrolled for its Phase IIa Clinical Trial for Alzheimer’s Disease and Agitation
7:28am
6-K
5xdd38f46b7hyj bp
21 Apr 23
SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression
9:12am
6-K
e6kjtnh rwnc239wh
4 Apr 23
SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome
5:48pm
6-K
ledjtl14a83f1s5sfn
4 Apr 23
SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million
7:07am
6-K
xipk 38sb
10 Mar 23
SciSparc Receives Approval to conduct its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome
5:00pm
6-K
n5gh htlo25g0cwjnf
7 Mar 23
SciSparc Successfully Completed Production of its Proprietary Drug Candidate SCI-110 for its Upcoming Clinical Trial On Tourette Syndrome
6:02am
6-K
pz6288
27 Feb 23
SciSparc Signs Agreement for the Supply of CBD-rich Cannabis Oil for its Clinical Trial on Children with Autism Spectrum Disorder
9:13am
6-K
vyoiu s3bimnm8g
27 Feb 23
SciSparc Signs a Definitive Agreement to Sell 49% interest in its Subsidiary that Owns Wellution for $2.5 million
7:46am
6-K
b4lo ow2be55
17 Feb 23
SciSparc’s Drug Discovery Joint Venture MitoCareX Bio Successfully Reached First Milestone for its Future Machine Learning System
4:05pm
6-K
hh6z4lsn4f5f hsnb
16 Feb 23
Report of Foreign Private Issuer
5:24pm
6-K
ein1sj
15 Feb 23
SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Three Provisional Patent Applications in the US
8:32am
6-K
aiymrp2diwiugnu7
25 Jan 23
SciSparc Announces Corporate Restructuring plan
4:15pm
6-K
lr5pr8 4svz6sj
23 Jan 23
SciSparc to Investigate and Evaluate Concerns of Illegal Trading of its Ordinary Shares
4:10pm
6-K
ub88qlp9
18 Jan 23
SciSparc Receives Approval to Conduct its Clinical Trial in Children with Autism Spectrum Disorder at the Soroka Medical Center
4:15pm
6-K
1shtzy8djpegug32qdx
9 Jan 23
SciSparc Signs Agreement to Conduct its Clinical Trial in Autism Spectrum Disorder with Soroka Medical Center
4:01pm